Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • Medical Jobs
  • Medical Matrimony
  • MD Brand Connect
  • MDTV
    • Anesthesia
    • CTVS
    • Cardiology
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • Diet and nutrition
    • ENT
    • Gastroenterology
    • Health Dialogues
    • Health News today
    • Health Shorts
    • Health Updates
    • Health video of the day
    • Laboratory Medicine
    • Latest Videos
    • Latest Webinars
    • MD shorts
    • Medical News Today
    • Medical Updates
    • Medical Video of the day
    • Medicine
    • Medico Legal Update
    • Nephrology
    • Neurology and Neurosurgery
    • Obstetrics and Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics & Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Top Videos
    • Urology
Medical Dialogues
  • Medical News
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • MCI News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • Medical Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Aborad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
    • Pharmacy Education News
  • MDTV
      • Anesthesia
      • CTVS
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • Diet and nutrition
      • ENT
      • Gastroenterology
      • Health Dialogues
      • Health News today
      • Health Shorts
      • Health Updates
      • Health video of the day
      • Laboratory Medicine
      • Latest Videos
      • Latest Webinars
      • MD shorts
      • Medical News Today
      • Medical Updates
      • Medical Video of the day
      • Medicine
      • Medico Legal Update
      • Nephrology
      • Neurology and Neurosurgery
      • Obstetrics and Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics & Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Top Videos
      • Urology
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • MCI News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • Medical Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Aborad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
  • Case of the Day
  • Editorial
  • Home
  • Radiology
  • Radiology News
  • Prevention and...

Prevention and management of contrast-associated acute kidney injury: CAR Guideline

Medha BaranwalWritten by Medha Baranwal Published On 2022-06-24T09:15:55+05:30  |  Updated On 2022-06-24T14:37:32+05:30
Prevention and management of contrast-associated acute kidney injury: CAR Guideline
  • Facebook
  • Twitter
  • Whatsapp
  • Telegram
  • Linkedin
  • Email
  • koo
  • Facebook
  • Twitter
  • Whatsapp
  • Telegram
  • Linkedin
  • Email
  • koo
  • Facebook
  • Twitter
  • Whatsapp
  • Telegram
  • Linkedin
  • Email
  • koo

Canada: A recent article, published in the Canadian Association of Radiologists Journal, reports guidance on contrast associated acute kidney injury.

Iodinated contrast media (ICM) is one of the most frequently administered pharmaceuticals. The occurrence of acute kidney injury (AKI) after ICM administration is historically considered a common iatrogenic complication which was managed by screening patients, prophylactic strategies, and follow-up evaluation of renal function.

Initially, the Canadian Association of Radiologists (CAR) published guidelines on the prevention of contrast-induced nephropathy in 2007, with an update in 2012. However, the new developments in the field have resulted in the availability of safer contrast agents and changes in clinical practice, prompting a complete revision of the earlier recommendations.

The revised guidance was developed by a multidisciplinary CAR Working Group of radiologists and nephrologists. It summarizes changes in practice related to contrast administration, screening, and risk stratification since the last guideline. It reviews the scientific evidence for contrast associated AKI and provides consensus-based recommendations for its prevention and management in the context of Canadian healthcare.

This article is a joint publication in the Canadian Association of Radiologists Journal and Canadian Journal of Kidney Health and Disease, intended to inform both communities of practice. Given below is a summary of the 2022 recommendations.

Risk Stratification

These screening guidelines focus on balancing risks (risk of CA-AKI, patient delays, and healthcare costs) as well as significant benefits of timely contrast-enhanced diagnostic imaging.

  • For stable outpatients without a current (3- 6 months depending on institutional preference) eGFR on file, and those without a provided history of CKD on the requisition, the authors recommend a simple screening questionnaire to detect those who may have AKI or severe CKD.
  • A current eGFR (within 7 days for inpatients, or upon presentation for ER patients) is recommended, however this should not delay emergent imaging examination.
  • or non-emergent presentation of stable outpatients, inpatients, and emergency patients when eGFR is available.

Choice of contrast

  • The authors do not recommend preferential use of iso-osmolar ICM for reducing risk of CA-AKI; those decisions should be made based on other factors (e.g., cost and availability).
  • The authors discourage reduced dosing of IV contrast administration for CT examinations since that lowers parenchymal enhancement and recommend using the appropriate IV dose for high quality CT imaging in all patients.
  • A pragmatic approach to ICM dosing for IA interventions using the necessary dose is recommended to achieve the diagnostic and therapeutic results but judiciously reducing dose when adjunctive imaging and doses are low yield or can be delayed.
  • The authors do not recommend restricting repeat contrast doses in lower risk patients (eGFR >30, no AKI, IV route) or withholding repeat doses for emergency or inpatients who have life-threatening, or acute presentation of illness. The authors do recommend avoiding repeated contrast exposures within 48 hours for elective procedures if the patients at higher risk of CA-AKI (eGFR ≤30, AKI, intraarterial ICM administration). However, in the face of life-threatening illness, repeat dosing of ICM may be necessary and justified to establish a confident diagnosis and treatment plan.

Prophylaxis of CA-AKI

  • The authors do not recommend oral or intravenous hydration for patients with eGFR >30 mL/min/1.73m2, receiving intravenous or intra-arterial ICM.
  • or patients with eGFR ≤30 mL/min/1.73m2, receiving intravenous ICM, there is a lack of evidence on the benefit of volume expansion. Hence the working group makes no recommendation in this regard; institutions may choose practices best suited to their local environments.
  • or patients with eGFR ≤30 mL/min/1.73m2, receiving intra-arterial ICM, some members of the working group endorsed a strategy of hydration and volume expansion using either intravenous hydration (with .9% saline or 1.26% sodium bicarbonate) or oral salt and water. Since there is insufficient evidence in this patient group the working group felt the use of hydration or not, and the route of hydration was best left to the judgment of the practitioner.
  • The authors do not recommend the preferential use of iso-osmolar ICM for reducing the risk of CA-AKI. We recommend decisions about low-osmolar or iso-osmolar ICM be made based on other factors (e.g., cost and availability).
  • The authors do not recommend any form of post-ICM administration renal replacement therapy, either dialysis or continuous renal replacement therapy for reduction of the risk of CA-AKI.
  • The authors do not recommend N-acetylcysteine use for the prophylaxis of CA-AKI.
  • The authors do not recommend initiating statins specifically for the prevention of CA-AKI.
  • The authors do not recommend use of other pharmacological agents which have been described in the literature, including theophylline, prostaglandin E1, nicorandil, ascorbic acid, allopurinol, alpha-tocopherol, fenoldopam, natriuretic peptides, and trimetazidine.

Medication considerations

  • The authors do not recommend stopping metformin before contrast injection, and/or re-testing kidney function afterwards, for patients with eGFR >30 mL/min/1.73 m2.
  • The authors recommend that in patients with eGFR ≤30 mL/min/1.73m2 or AKI, metformin should be held at the time of, or prior to, ICM administration. Metformin should not be restarted for at least 48 hours and only then if kidney function remains stable (<25% increase compared with baseline creatinine) and the ongoing use of metformin has been re-assessed by the patient's clinical team.
  • The authors do not recommend routinely discontinuing renin-angiotensin system inhibitors (ACEi and ARBs) prior to, or after, ICM administration.
  • Routinely discontinuing diuretics prior to, or after, ICM administration is not recommended.

Post ACM administration statements

  • The authors recommend a follow-up serum creatinine measurement 48 to 72 hours after intra-arterial ICM injection in all patients with eGFR ≤30 mL/min/1.73m2. For the remainder of the patients, the risk of AKI is extremely low, and routine testing is not warranted. However, any at-risk patient should be instructed to seek medical attention and kidney function testing if they develop increased shortness of breath, peripheral edema, or note a marked decline in urine output in the days following the imaging test.
  • The authors recommend that clinical evaluation and management of AKI due to CA-AKI be undertaken according to the Kidney Disease Improving Global Outcomes (KDIGO) clinical practice guidelines for AKI and taking into account the Canadian Society of Nephrology (CSN) commentary on those guidelines.

Reference:

1. Macdonald DB, Hurrell C, Costa AF, et al. Canadian Association of Radiologists Guidance on Contrast Associated Acute Kidney Injury. Canadian Association of Radiologists Journal. May 2022. doi:10.1177/08465371221083970


Canadian Association of Radiologists Journal Iodinated contrast media acute kidney injury 
Source : Canadian Association of Radiologists Journal
Medha Baranwal
Medha Baranwal

    Medha, MSc. Biotechnology

    Medha Baranwal joined Medical Dialogues as an Editor in 2018 for Speciality Medical Dialogues. She covers several medical specialties including Cardiac Sciences, Dentistry, Diabetes and Endo, Diagnostics, ENT, Gastroenterology, Neurosciences, and Radiology. She has completed her Bachelors in Biomedical Sciences from DU and then pursued Masters in Biotechnology from Amity University. She has a working experience of 5 years in the field of medical research writing, scientific writing, content writing, and content management. She can be contacted at  editorial@medicaldialogues.in. Contact no. 011-43720751

    Show Full Article
    Next Story
    Similar Posts
    NO DATA FOUND

    Editorial

    Management of Allergic Rhinitis during COVID-19 Pandemic

    Management of Allergic Rhinitis during COVID-19 Pandemic

    Role of Probiotics in recurrent bacterial vaginosis: A review

    Role of Probiotics in recurrent bacterial vaginosis: A review

    Bronchial Asthma - Early Indicators for Diagnosis and Its Management in Indian Practice Settings

    Bronchial Asthma - Early Indicators for Diagnosis and Its Management in Indian Practice Settings

    Role of metoprolol tartrate in management of acute myocardial infarction in the present era

    Role of metoprolol tartrate in management of acute myocardial infarction in the present era

    Managing co-existing allergic rhinitis and asthma: Analyzing the role of Montelukast-levocetirizine combination

    Managing co-existing allergic rhinitis and asthma: Analyzing the role of Montelukast-levocetirizine...

    View All

    Journal Club Today

    Spending time online to help boosting childrens well-being

    Spending time online to help boosting children's well-being

    View All

    Health News Today

    Health Bulletin 27/June/2022

    Health Bulletin 27/June/2022

    View All
    © 2022 All Rights Reserved.
    Powered By: Hocalwire
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok
    X
    X